Business Context and Reporting Period
Company: Intensity Therapeutics, Inc. (INTS)
Filing Type: Form 8-K (Current Report)
Report Date: May 7, 2026
Reporting Period: Three months ended March 31, 2026
Context: The filing announces the release of financial results for the first quarter of 2026. The company is designated as an emerging growth company.
Key Financial Metrics
The provided Form 8-K text serves as a notification of results and does not contain specific financial data points. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are located in the attached press release (Exhibit 99.1) and the corresponding Form 10-Q, which are referenced but not included in this text.
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not disclose specific material changes in financial condition or operations compared to prior periods. It directs readers to the press release and Form 10-Q for detailed comparative analysis.
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing includes a cautionary statement noting that comments contain forward-looking statements based on management's expectations. Actual results may differ materially due to various risks and uncertainties.
Risk Factors: Specific risks are not detailed in this 8-K but are referenced as being described in the Company's Annual Report on Form 10-K (filed March 27, 2026) and the Quarterly Report on Form 10-Q (filed May 7, 2026).
Unusual Items: No unusual items are explicitly detailed in the text of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 financial figures.
- Examine the Form 10-Q filed on May 7, 2026, for detailed financial statements and management discussion.
- Consult the Form 10-K filed on March 27, 2026, for a comprehensive list of risk factors.
- Verify the company's status as an emerging growth company and any associated accounting election impacts.